Valuation: Consun Pharmaceutical Group Limited

Capitalization 1.28TCr 1.44TCr 184.53Cr 157.27Cr 145.72Cr 137.05Cr 255.1Cr 17TCr 273.64Cr 1.68TCr 664.52Cr 7.99TCr 691.98Cr 677.79Cr 29TCr P/E ratio 2025 *
11.8x
P/E ratio 2026 * 10.4x
Enterprise value 985.09Cr 1.1TCr 141.54Cr 120.63Cr 111.77Cr 105.12Cr 195.67Cr 13TCr 209.89Cr 1.29TCr 509.71Cr 6.13TCr 530.77Cr 519.88Cr 22TCr EV / Sales 2025 *
2.87x
EV / Sales 2026 * 2.37x
Free-Float
50.22%
Yield 2025 *
4.28%
Yield 2026 * 4.81%
More valuation ratios * Estimated data
Dynamic Chart
07/11 Consun Pharmaceutical Proposes Share Award Scheme to Incentivize Staff; Shares Slip 2% MT
25/25/25 Consun Pharmaceutical says executive director Zhu Quan redesignated as non-executive director RE
25/25/25 Consun Pharmaceutical Group says Zhu Quan redesignated as a non-executive director RE
25/25/25 Consun Pharmaceutical Group Limited Announces Redesignation of Zhu Quan from Executive Director to Non-Executive Director, Effective 25 September 2025 CI
19/25/19 Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2025 CI
19/25/19 Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2025 , Payable on September 19, 2025 CI
19/25/19 Consun Pharmaceutical Group's H1 Profit Jumps 25% MT
19/25/19 Tranche Update on Consun Pharmaceutical Group Limited's Equity Buyback Plan announced on June 16, 2025. CI
04/25/04 Consun Pharmaceutical says Horogos Consun subscribes wealth product for RMB252 million RE
20/25/20 Consun Pharmaceutical Group Limited Announces Nomination Committee Changes, Effective from 20 June 2025 CI
16/25/16 Consun Pharmaceutical Group Limited commences an Equity Buyback for 85,126,334 shares, representing 10% of its issued share capital, under the authorization approved on June 16, 2025. CI
13/25/13 Consun Pharmaceutical To Implement Share Repurchase Program Of Up To HKD200 Million RE
22/25/22 Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2024 CI
More news
1 day+0.06%
1 week+5.62%
Current month+9.40%
1 month+7.54%
3 months+13.54%
6 months+38.21%
Current year+9.40%
More quotes
1 week 16.45
Extreme 16.45
17.4
1 month 15.3
Extreme 15.3
17.4
Current year 15.3
Extreme 15.3
17.4
1 year 7.55
Extreme 7.55
17.68
3 years 4.07
Extreme 4.07
17.68
5 years 2.92
Extreme 2.92
17.68
10 years 2.61
Extreme 2.61
17.68
More quotes
Manager TitleAgeSince
Chief Executive Officer 54 17/01/2024
Director of Finance/CFO 46 24/02/2025
Corporate Secretary 58 -
Director TitleAgeSince
Director/Board Member 86 24/12/2012
Director/Board Member 67 02/12/2013
Chairman 54 09/07/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.06%+5.62%+123.66%+314.29% 184.35Cr
-3.68%-7.04%-9.67%+55.09% 4.42TCr
-0.75%+2.27%+50.26% - 3.34TCr
+0.91%-1.50%+12.46%+116.80% 2.96TCr
-1.00%-5.92%-4.43%+29.45% 1.24TCr
-0.87%-2.42%-12.19%+97.67% 975.68Cr
-0.75%-3.77%+70.23%+40.07% 832.82Cr
-1.36%+0.46%+46.80%+127.08% 783.87Cr
-.--%+0.14% - - 678.76Cr
+0.58%-0.70%+39.38%-21.92% 666.8Cr
Average -0.70%-0.76%+35.17%+94.82% 1.61TCr
Weighted average by Cap. -1.24%-1.36%+18.74%+74.40%
See all sector performances

Financials

2025 *2026 *
Net sales 342.74Cr 384.04Cr 49Cr 42Cr 39Cr 37Cr 68Cr 4.48TCr 73Cr 448.89Cr 177.34Cr 2.13TCr 184.67Cr 180.88Cr 7.78TCr 385.16Cr 431.56Cr 55Cr 47Cr 44Cr 41Cr 77Cr 5.04TCr 82Cr 504.44Cr 199.29Cr 2.39TCr 207.52Cr 203.27Cr 8.74TCr
Net income 108.88Cr 122Cr 16Cr 13Cr 12Cr 12Cr 22Cr 1.42TCr 23Cr 142.6Cr 56Cr 677Cr 59Cr 57Cr 2.47TCr 123.49Cr 138.37Cr 18Cr 15Cr 14Cr 13Cr 25Cr 1.61TCr 26Cr 161.74Cr 64Cr 767.88Cr 67Cr 65Cr 2.8TCr
Net Debt -299.2Cr -335.25Cr -43Cr -37Cr -34Cr -32Cr -59Cr -3.91TCr -64Cr -391.86Cr -154.81Cr -1.86TCr -161.21Cr -157.9Cr -6.79TCr -369.6Cr -414.13Cr -53Cr -45Cr -42Cr -39Cr -73Cr -4.83TCr -79Cr -484.07Cr -191.24Cr -2.3TCr -199.14Cr -195.06Cr -8.39TCr
More financial data * Estimated data
Logo Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Employees
3,073
More about the company
Date Price Change Volume
20/26/20 17.11 $ +0.06% 8,49,996
19/26/19 17.10 $ -0.93% 9,43,190
16/26/16 17.26 $ +1.47% 11,15,436
15/26/15 17.01 $ +2.41% 10,30,000
14/26/14 16.61 $ +0.97% 11,45,831

Delayed Quote Hong Kong S.E., January 20, 2026 at 01:38 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
15.27CNY
Average target price
17.10CNY
Spread / Average Target
+11.96%
Consensus

Annual profits - Rate of surprise